Conclusion
In summary, we report a E-BSI incidence of 2.7%. Further research is needed to continue to evaluate the incidence and factors such as prophylactic antimicrobials, duration of support, and site and location of cannulation that contribute to E-BSI and its effect on morbidity and mortality. Future directions would include expanding data collection to VA-ECMO to identify differences in risk factors and outcomes compared to the VV-ECMO.
  1. Seidelman JL, Lewis SS, Huslage K, et al. To Be a CLABSI or Not to Be a CLABSI-That is the Question: The Epidemiology of BSI in a Large ECMO Population. Infect Control Hosp Epidemiol . 2018;39(3):362-365.
  2. Na SJ, Chung CR, Choi HJ, et al. Blood Stream Infection in Patients on Venovenous Extracorporeal Membrane Oxygenation for Respiratory Failure. Infect Control Hosp Epidemiol . 2018;39(7):871-874.
  3. Farrell D, MacLaren G, Schlapbach LJ. Infections on Extracorporeal Life Support in Adults and Children-A Survey of International Practice on Prevention, Diagnosis, and Treatment. Pediatr Crit Care Med . 2019;20(7):667-671.
  4. Haneke F, Schildhauer TA, Schlebes AD, Strauch JT, Swol J. Infections and Extracorporeal Membrane Oxygenation: Incidence, Therapy, and Outcome. ASAIO J . 2016;62(1):80-86.
  5. Juthani BK, Macfarlan J, Wu J, Misselbeck TS. Incidence of nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation. Heart Lung . 2018;47(6):626-630.
  6. Selçuk ÜN, Sargın M, Baştopçu M, et al. Microbiological Spectrum of Nosocomial ECMO Infections in a Tertiary Care Center. Braz J Cardiovasc Surg . 2021;36(3):338-345
  7. Menaker J, Galvagno S, Rabinowitz R, et al. Epidemiology of blood stream infection in adult extracorporeal membrane oxygenation patients: A cohort study. Heart Lung . 2019;48(3):236-239.
  8. Thomas G, Hraiech S, Cassir N, et al. Venovenous extracorporeal membrane oxygenation devices-related colonisations and infections.Ann Intensive Care . 2017;7(1):111.